檢測編號: *HYMDD+

抗藥性乙型肝炎病毒基因型鑑定 (Lamivudine, Telbivudine, Adefovir, Entecavir 抗藥性基因型) , 定性PCR, 附加於HBVQ


檢測方法:

Hepatitis B virus (HBV) with drug resistance (DR) mutation is detected with PCR followed by hybridization and visualization on a membrane strip. The multipex PCR amplification targets on 5 hot spots of drug resistance associated mutations, namely rtM250V, rtA181V, rtN236T, rtM204l and rtM204V. Different combinations of these mutation hot spots are associated with antiviral drug Lamivudine, Telbivudine, Adefovir and Entecavir resistance.


標本種類: 

附加於HBV



檢測時間 : 

不多於 3 天